Английская Википедия:Basmisanil
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
Basmisanil (Шаблон:Abbrlink; developmental codes RG-1662 and RO5186582) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome.[1][2][3] As of June 2016, it is no longer studied.[4] It is studied with schizophrenia patients.[5]
See also
- List of investigational antipsychotics
- GABAA receptor negative allosteric modulator
- GABAA receptor § Ligands
References
External links
Шаблон:GABA receptor modulators
Шаблон:Nervous-system-drug-stub